AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2021

Mar 19, 2021

32777_dirs_2021-03-19_ead60718-df07-4297-9d5d-3ab2045ce554.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2021-03-17

Reporting Person: Legault Pierre (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-17	Ordinary Shares	M	7784	$8.85	Acquired	7784	Direct
2021-03-17	Ordinary Shares	S	7784	$29.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-17	Stock Option (Right to Buy)	$8.85	M	7784	Disposed	2029-04-25	Ordinary Shares (7784)	Direct

Footnotes

F1: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3898 to GBP 1.00 as of March 17, 2021.

F2: This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022.